Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics

Uncertainty exists regarding safety and efficacy of dual biological therapy (DBT) in inflammatory bowel disease. We present four cases of DBT in Crohn’s disease. Three patients had refractory disease non-responsive to biological monotherapy or combination therapy with immunomodulators. One patient h...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMJ Open Gastroenterol
Hoofdauteurs: Mao, Eric J, Lewin, Sara, Terdiman, Jonathan P, Beck, Kendall
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2018
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254738/
https://ncbi.nlm.nih.gov/pubmed/30538822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2018-000243
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items